NCT03882788View on ClinicalTrials.gov

The Effect of Anesthesia on Neurodevelopmental Outcome (NDO)

NACompletedINTERVENTIONAL
Enrollment

153

Participants

Timeline

Start Date

April 22, 2013

Primary Completion Date

November 19, 2020

Study Completion Date

November 19, 2020

Conditions
Anesthesia; Adverse EffectCongenital Heart DiseaseNeurodevelopmental Disorders
Interventions
DRUG

Isoflurane

Isoflurane (volatile anesthesia) will be delivered at 1.5-2.0%% as required for anesthetic management.

DRUG

Fentanyl (high dose)

Fentanyl (narcotic anesthesia) maintenance will be with fentanyl 5 mcg/kg/hr not to exceed 10 mcg/kg/hr.

DRUG

Fentanyl (low dose)

Fentanyl (narcotic anesthesia) maintenance will be with fentanyl 2 mcg/kg/hr.

Trial Locations (1)

94305

Stanford Childrens hospital, Palo Alto

All Listed Sponsors
collaborator

The Gerber Foundation

OTHER

lead

Stanford University

OTHER

NCT03882788 - The Effect of Anesthesia on Neurodevelopmental Outcome (NDO) | Biotech Hunter | Biotech Hunter